B3255 - Microalbuminuria causes and long-term consequences in the general population - 29/04/2019

B number: 
B3255
Principal applicant name: 
Valentina Gracchi | Beatrix Children's Hospital, University Medical Center Groningen (The Netherlands) (The Netherlands)
Co-applicants: 
Prof Hiddo Lambers Heerspink, PharmD, PhD, Prof Henkjan Verkade, MD, PhD, Richard Coward, MBChB FRCPCH PhD , Alix Groom, BsC, PhD
Title of project: 
Microalbuminuria: causes and long-term consequences in the general population.
Proposal summary: 

Albumin is a protein present in blood and excreted in urine. Slight increases of levels of albumin excretion in urine (so called microalbuminuria) are related to an increased risk for renal and cardiovascular disease, even in otherwise healthy individuals. Nevertheless, the exact cause and the underlying mechanism of microalbuminuria are still unknown. Moreover, data on microalbuminuria in young individuals are scarce.
With this project we intend to learn more about the prevalence of microalbuminuria in school-aged children and young adults. We also want to test the hypothesis that some individuals have higher urinary albumin levels already early in life, that these findings persist in time and that such individuals carry a higher risk for renal, cardiovascular and, possibly, metabolic disease.
Moreover, we intend to explore possible causes of microalbuminuria, evaluating genetic background and associations between albuminuria and antenatal and postnatal determinants.
We plan to integrate the extensive data from the ALSPAC cohort with data from the Dutch GECKO birth-cohort (Groningen, The Netherlands), where urine samples have been collected at a younger age and thorough information about obesity risk factors are available. By investigating these two cohorts, we aim to gather data describing the spectrum of albuminuria from early childhood into young adulthood.

Impact of research: 
If the results of this research project will confirm that some individuals have high urinary albumin levels already early in life and that these findings persist in time, this could support the hypothesis of microalbuminuria as an expression of congenital endothelial dysfunction, leading to an increased renal, cardiovascular and possibly also metabolic risk. It could also be possible to identify genetic risk profiles or antenatal and postnatal determinants. This can have relevant consequences for health care policies (ex. extra controls for at risk groups or earlier therapeutic interventions where needed). Investigating the possible causes can help to identify strategies for primary and secundary prevention and to define the at risk groups.
Date proposal received: 
Saturday, 9 February, 2019
Date proposal approved: 
Wednesday, 13 February, 2019
Keywords: 
Clinical research/clinical practice, Hypertension, cardiovascular (incl hypertension), renal, metabolic profile, GWAS, URINE samples: Albumin: immunoturbidimetric assay Creatinine: enzymatic assay Urea: kinetic test with urease and glutamate dehydrogenase Sodium: indirect ISE Potassium: indirect ISE PLASMA EDTA samples: Creatinine: enzymatic assay Urea: kinetic test with urease and glutamate dehydrogenase Uric acid: enzymatic assay , Biological samples -e.g. blood, cell lines, saliva, etc., Biomarkers - e.g. cotinine, fatty acids, haemoglobin, etc., Blood pressure, BMI, Cardiovascular, Genetics, Genome wide association study, Kidney function, Metabolic - metabolism